Skip to content

Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus

Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02467179
Acronym
Amigo-AFL
Enrollment
50
Registered
2015-06-09
Start date
2015-03-31
Completion date
2018-03-30
Last updated
2019-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Atrial Flutter

Keywords

Arrhythmia, cavo-tricuspid isthmus, atrial fibrillation, atrial fibrillation ablation

Brief summary

The purpose of this study is to compare standard manual and robotically controlled catheter ablation of the cavo-tricuspid isthmus (CTI) as a treatment for atrial flutter. Ablation of the CTI is standard treatment for patients with a history of atrial flutter, and those undergoing ablation for atrial fibrillation. Both manual and robotic catheter manipulation are used in standard clinical practice at The University of California, San Diego (UCSD) for ablation.

Detailed description

Dr. Gregory Feld, M.D. is conducting a research study to find out more about the effects of using the Amigo™ Robotic System for ablation of the cavo-tricuspid isthmus (flutter isthmus) on catheter stability (stabilization of the catheter during the procedure in order to prevent movement and dislodgement) using a combination of contact force (a measurement of the force applied by the catheter tip against the tissue during the ablation procedure), location, and duration measurements during ablation of the atrial flutter circuit. Published studies have indicated that robotic catheter manipulation is safe, may reduce patient and physician x-ray exposure, and ablation procedure time. Measuring contact force has also been shown to improve both short-term and long-term procedure success. However, research on ablation of the CTI specifically, is limited. This is a randomized study comparing robotic catheter manipulation using the Amigo Robotic System to manual catheter manipulation for ablation of the CTI on measures including catheter stability, contact force, procedure time, and fluoroscopy (X-ray) time. The ablation procedure is standard of care, however, if patients chose to enroll in the study they will be randomized to one of two groups: either manual or robotic catheter manipulation. Throughout the procedure, research personnel will collect information from the procedure including measurements of contact force, catheter stability, procedure duration, and fluoroscopy (X-ray) time. If, in addition to ablation of the cavo-tricuspid isthmus for atrial flutter, a patient is scheduled to undergo ablation of the left atrium for atrial fibrillation or left atrial flutter, this will be performed subsequently in a standard manner, and will not be considered part of the research. Ablation of the CTI generally takes 45-60 minutes regardless of the technique used for manipulation of the catheters. The patient's participation in the study will only last one day, the length of study procedure. There is no follow up associated with this study. All subjects will received standard of care treatment following their ablation.

Interventions

DEVICEAmigo™ Robotic Catheter Manipulation

Ablation is a standard procedure that patients may undergo for the atrial flutter. In this study, this group will be assigned to robotic catheter manipulation.

DEVICEManual Catheter Manipulation

Ablation is a standard procedure that patients may undergo for the atrial flutter. In this study, this group will be assigned to manual catheter manipulation.

Sponsors

Catheter Robotics, Inc.
CollaboratorINDUSTRY
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be scheduled to undergo radiofrequency catheter ablation of the cavo-tricuspid isthmus for atrial fibrillation (AF) or atrial flutter (AFL) according to appropriate clinical indications. * Must be able and willing to provide written informed consent * Must be at least 18 years old.

Exclusion criteria

* Patient's refusal to participate in the study * Lack of indication for CTI ablation (eg: prior CTI ablation with persistent bidirectional isthmus block) * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Contact Force Through Measurement of Force-time Integral (FTI)At time of the ablation procedure, which typically lasts 30-60 minutesDetermination of the average total contact force (measured in gs) achieved during each ablation lesion using the Carto Mapping System

Secondary

MeasureTime frameDescription
Fluoroscopy Time Measurementsat time of ablation procedureDetermine fluoroscopy time to reach CTI block.

Countries

United States

Participant flow

Participants by arm

ArmCount
Manual Catheter Manipulation
25 subjects will be randomized to this arm. Manual catheter ablation of the cavo-tricuspid isthmus will be performed. Manual Catheter Manipulation: Ablation is a standard procedure that patients may undergo for the atrial flutter. In this study, this group will be assigned to manual catheter manipulation.
25
Amigo™ Robotic Catheter Manipulation
25 subjects will be randomized to this arm. Robotic catheter ablation of the cavo-tricuspid isthmus with the Amigo Catheter System will be performed. Amigo™ Robotic Catheter Manipulation: Ablation is a standard procedure that patients may undergo for the atrial flutter. In this study, this group will be assigned to robotic catheter manipulation.
25
Total50

Baseline characteristics

CharacteristicAmigo™ Robotic Catheter ManipulationTotalManual Catheter Manipulation
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
25 Participants50 Participants25 Participants
Age, Continuous63 years
STANDARD_DEVIATION 12
63 years
STANDARD_DEVIATION 12
63 years
STANDARD_DEVIATION 12
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
25 participants50 participants25 participants
Sex: Female, Male
Female
6 Participants14 Participants8 Participants
Sex: Female, Male
Male
19 Participants36 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Contact Force Through Measurement of Force-time Integral (FTI)

Determination of the average total contact force (measured in gs) achieved during each ablation lesion using the Carto Mapping System

Time frame: At time of the ablation procedure, which typically lasts 30-60 minutes

ArmMeasureValue (MEAN)Dispersion
Manual Catheter ManipulationContact Force Through Measurement of Force-time Integral (FTI)471 gm/sStandard Deviation 179
Amigo™ Robotic Catheter ManipulationContact Force Through Measurement of Force-time Integral (FTI)571 gm/sStandard Deviation 278
Secondary

Fluoroscopy Time Measurements

Determine fluoroscopy time to reach CTI block.

Time frame: at time of ablation procedure

ArmMeasureValue (MEAN)Dispersion
Manual Catheter ManipulationFluoroscopy Time Measurements3.8 minutesStandard Deviation 2.3
Amigo™ Robotic Catheter ManipulationFluoroscopy Time Measurements6.8 minutesStandard Deviation 4.4

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026